Chad Golder
General Counsel & Secretary
General Counsel and Secretary | American Hospital Association
Last verified November 4, 2026
Affiliations
- •General Counsel and Secretary of the AHA since January 2024 (listed on the 2024 Form 990 as SVP, General Counsel & Secretary), succeeding Melinda Hatton; previously Deputy General Counsel. He remains on the Executive Management Group under CEO Steve Walsh as of November 2026.
- •Former partner and founding member of Munger, Tolles & Olson's Washington office, opened in 2016 with former U.S. Solicitor General Donald Verrilli.
- •Former senior Justice Department official, including Deputy Associate Attorney General and Counsel to the Deputy Attorney General in the Obama administration, working on ACA litigation among other matters.
- •Former Assistant U.S. Attorney in the Eastern District of Virginia.
- •Former law clerk to Justice John Paul Stevens and to Judge Merrick Garland on the D.C. Circuit.
Financial / Compensation
- •Golder's reportable 2024 compensation in his first year as General Counsel was $1,070,865 plus $154,122 in other compensation, about $1.22 million total, per AHA's 2024 Form 990.
- •That is up from $797,836 in 2023 as Deputy General Counsel, per Paddock Post, a raise of roughly 34% in reportable pay on promotion.
- •His predecessor Melinda Hatton received $297,327 in 2024 reportable compensation after her role ended in December 2023.
- •AHA's 2024 Form 990 reports total revenue of $146.7 million against expenses of $169.3 million, a $22.6 million operating deficit, with net assets falling from $289.8 million to $277.6 million during the year.
- •Former CEO Rick Pollack's reportable 2024 compensation was $5,823,759 (plus $55,174 other compensation), up from $3,396,123 in 2023.
- •Senior executives at AHA receive taxable benefit allowances (SVPs and above) and access to a supplemental non-qualified deferred compensation plan, per the 2023 Form 990.
Lobbying and Political
- •Golder is not a registered federal lobbyist on AHA's 2025 or 2026 LDA reports; his tool is litigation against HHS, CMS and HRSA.
- •AHA's in-house LDA reports show $25.47 million in federal lobbying for 2025 (Q1 $7.03M, Q2 $6.15M, Q3 $5.72M, Q4 $6.57M); that total already includes about $1.68 million paid to outside lobbying firms.
- •AHA's 2026 in-house lobbying fell sharply during the CEO transition: $6.08 million in Q1, $4.47 million in Q2 and $3.84 million in Q3, or $14.39 million year to date, plus about $1.07 million to outside firms.
- •AHAPAC reported $3.49 million in receipts for the 2025-2026 cycle through Oct. 14, 2026, with $2.30 million in contributions to other committees, $1.26 million in independent expenditures, and cash on hand down to $683,005.
Revolving Door
- •DOJ to BigLaw to trade association: he defended federal agencies' authority at DOJ, then went to an elite firm's government-facing DC office, and now runs a legal shop that sues the same agencies.
- •His Munger Tolles DC office was built around Obama-era Solicitor General Donald Verrilli.
- •No current government advisory roles or outside corporate board seats are publicly reported.
Home System Record
- •Under Golder, AHA won the most consequential hospital-side court fight of 2025-2026: the Dec. 29, 2025 injunction that killed HRSA's first 340B rebate pilot.
- •AHA filed an amicus brief on June 17, 2026 in the 5th Circuit supporting Texas against HHS and CMS on Medicaid provider-tax 'hold harmless' rules, defending a state financing mechanism critics say inflates federal Medicaid matching dollars.
- •Before his tenure, AHA lost its challenge to the CMS price transparency rule at district court and on appeal in 2020, and lost its site-neutral case when the D.C. Circuit reversed its win and the Supreme Court declined review in 2021.
- •AHA won AHA v. Becerra unanimously at the Supreme Court in 2022, restoring 340B reimbursement rates.
Litigation and Scrutiny
- •340B rebate pilot (AHA, Maine Hospital Association and four safety-net systems v. HHS, D. Maine): preliminary injunction granted Dec. 29, 2025; 1st Circuit denied stay Jan. 7, 2026; government dropped appeal Jan. 20, 2026; HHS told the court Feb. 5, 2026 it would vacate the pilot.
- •Revised 340B rebate pilot: AHA and co-plaintiffs sued again Oct. 9, 2026 in D. Maine to stop the revised pilot set for Jan. 1, 2027; on Oct. 21, 2026 AHA asked the court to deny intervention motions by drug companies and PhRMA. Pending.
- •Texas v. HHS (5th Cir.): AHA, CHA, AAMC and FAH filed an amicus brief June 17, 2026 urging affirmance of a ruling that vacated parts of CMS's 2023 provider-tax bulletin and 2024 managed care rule.
- •Site-neutral (AHA v. Azar): AHA's 2019 district court win was reversed by the D.C. Circuit in 2020 and the Supreme Court declined review in 2021; this matter is closed, not an active front.
- •No bar discipline or personal litigation involving Golder has been publicly reported.
Red Flags
He uses DOJ-honed knowledge of how agencies defend rules to block them on behalf of hospitals, most effectively against 340B rebate reforms aimed at tracking how the discount is used.
AHA's courtroom strategy on the 340B program is to keep the discount flowing upfront and to stop rebate mechanisms that would expose claims data, protecting hospital spread revenue.
AHA's legal shop backs state provider-tax schemes in the 5th Circuit, which recycle federal Medicaid money through hospital taxes.
His pay jumped about 34% on promotion to roughly $1.22 million all-in for 2024, a year AHA ran a $22.6 million deficit.
The two biggest legal fights AHA lost on the merits, price transparency and site-neutral payment, were both efforts to keep hospital prices hidden and facility-fee markups intact.
Pattern Summary
Chad Golder is the AHA's chief litigator, a former senior DOJ lawyer and Munger Tolles partner who now sues HHS on the hospital lobby's behalf. On his watch AHA killed HRSA's first 340B rebate pilot in court and is back in the District of Maine to stop the revised version due Jan. 1, 2027. His promotion brought a roughly 34% raise to about $1.22 million in 2024, in a year AHA lost $22.6 million.
Sources and Citations
- 1.https://www.aha.org/about/leadership/executive-team
- 2.https://www.aha.org/system/files/media/file/2025/11/AHA-2024-IRS-Form-990-PDC.pdf
- 3.https://paddockpost.com/2025/07/08/executive-compensation-at-the-american-hospital-association-2023/
- 4.https://www.aha.org/news/headline/2026-01-20-government-drops-appeal-preliminary-injunction-order-aha-340b-lawsuit-rebate-model-program
- 5.https://www.aha.org/news/headline/2026-02-05-hhs-says-it-will-scrap-current-340b-rebate-model-program
- 6.https://www.aha.org/news/headline/2026-10-21-aha-urges-court-reject-drug-industry-intervention-340b-rebate-program-case
- 7.https://www.pharmaceuticalcommerce.com/view/inside-the-340b-rebate-pilot-standoff
- 8.https://www.aha.org/node/710362
- 9.https://wha.org/MediaRoom/WHANewsletter/2021/07-01-2021/U-S-Supreme-Court-Declines-to-Hear-AHA-Site-Neutra
- 10.https://www.medicaleconomics.com/view/hhs-responds-to-site-neutral-payment-challenge
- 11.https://projects.propublica.org/nonprofits/organizations/360726140
- 12.https://www.healthcaredive.com/news/american-hospital-association-new-ceo-steve-walsh/824120/
- 13.https://www.beckershospitalreview.com/finance/healthcares-top-lobbying-spenders-in-2026-so-far/
- 14.https://www.fec.gov/data/committee/C00106146/?cycle=2026
- 15.https://lda.gov/filings/public/filing/47352550-69dd-409a-b2a8-6959f1dc7782/print/
- 16.https://lda.gov/filings/public/filing/c56694f1-2658-4255-9c5b-42df25f3c8c0/print/
- 17.https://lda.gov/filings/public/filing/365bb0c0-f25c-4cdb-aea1-c8acf74e4f4c/print/
- 18.https://lda.gov/filings/public/filing/30300dfc-e44f-4a5b-aea0-2ab56070acfb/print/
- 19.https://lda.gov/filings/public/filing/a8e657fa-5ed0-4032-a521-3c1f39102e74/print/
- 20.https://lda.gov/filings/public/filing/59c316d6-b19d-47ac-9e37-2da885c38ad2/print/
- 21.https://lda.gov/filings/public/filing/5f715aae-6fa2-41fd-b465-39e61cd8a3f2/print/